02 9541 3500Using QCM-D in the development of broad-spectrum antiviral drugs
13 Apr, 2022 | Newsletters
| Considering the ongoing Covid-19 pandemic, and the tremendous negative impact it has had, and still has, antiviral drug development is a highly relevant topic. Here we present two studies where QSense QCM-D technology was used to explore viral membrane disruption and an antiviral strategy towards pandemic preparedness. Study A: Use QCM-D to analyse membrane−peptide interactions and membrane disruption Study B: Using QCM-D to analyse rupture of lipid vesicles by a Broad-Spectrum Antiviral Peptide and the influence of vesicle size |
| READ MORE HERE |
| Request a personal demo Request a quote now Email us for more info |